RecruitingNCT02448485

High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)

High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis


Sponsor

Medical University Innsbruck

Enrollment

10,000 participants

Start Date

Jun 1, 2015

Study Type

OBSERVATIONAL

Conditions

Summary

TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is measuring levels of a heart stress protein called high-sensitivity troponin T in the blood of patients with aortic stenosis — a narrowing of the heart's main outflow valve — to see if this blood test can predict which patients are at higher risk for complications. **You may be eligible if...** - You have aortic stenosis (narrowing of the heart valve) confirmed by an echocardiogram or heart catheterization **You may NOT be eligible if...** - You have recently had a heart attack (acute coronary syndrome) - You have an active infection of the heart valve (endocarditis) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAortic Valve Intervention (surgical or transcatheter)

Surgical or interventional aortic valve implantation


Locations(1)

Medical University Innsbruck

Innsbruck, Tyrol, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02448485


Related Trials